Clinical Trial Update: Effect of Anti-IgE in Chronic Urticaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-IgE therapy for chronic urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Anti-IgE therapy

Snippet

Sponsor: Johns Hopkins University | Conditions: Urticaria | Phase 2 | Status: COMPLETED